Press Releases (Page 207)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against VNET, Assertio, and Cummins and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of VNET Group, Inc. (NASDAQ: VNET), Assertio Holdings, Inc. (NASDAQ: ASRT), and Cummins Inc. (NYSE: CMI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about... ❯❯❯
ONSEMI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against ON Semiconductor Corporation and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against ON Semiconductor Corporation (“onsemi” or the “Company”) (NASDAQ: ON) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased or otherwise acquired onsemi common stock between May... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Brooge, and Cassava and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Brooge Energy Limited (NASDAQ: BROG), and Cassava Sciences, Inc. (NASDAQ: SAVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be... ❯❯❯
ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) on behalf of long-term stockholders following a class action complaint that was filed against Aldeyra on July 31, 2023 with a Class Period from March 17, 2022 to June 20, 2023. Our investigation concerns whether the board of... ❯❯❯
BEAUTY HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating The Beauty Health Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against The Beauty Health Company (NASDAQ: SKIN) on behalf of long-term stockholders following a class action complaint that was filed against Beauty Health on November 16, 2023 with a Class Period from May 10, 2022 to November 13, 2023. Our investigation concerns whether the... ❯❯❯
C3.AI ALERT: Bragar Eagel & Squire, P.C. is Investigating C3.ai, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against C3.ai, Inc. (NYSE: AI) on behalf of long-term stockholders following a class action complaint that was filed against C3.ai. Our investigation concerns whether the board of directors of C3.ai have breached their fiduciary duties to the company. The complaint alleges... ❯❯❯
WNS ALERT: Bragar Eagel & Squire, P.C. is Investigating WNS (Holdings) Limited on Behalf of WNS Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against WNS (Holdings) Limited (“WNS” or the “Company”) (NYSE: WNS) on behalf of WNS stockholders. Our investigation concerns whether WNS has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. ... ❯❯❯
AMYLYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amylyx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ: AMLX) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Amylyx securities between... ❯❯❯
CHILDREN’S PLACE ALERT: Bragar Eagel & Squire, P.C. is Investigating The Children’s Place on Behalf of Children’s Place Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against The Children’s Place (“Children’s Place” or the “Company”) (NASDAQ: PLCE) on behalf of Children’s Place stockholders. Our investigation concerns whether Children’s Place has violated the federal securities laws and/or engaged in other unlawful business practices. ... ❯❯❯
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioXcel Therapeutics, Inc. (NASDAQ: BTAI) on behalf of long-term stockholders following a class action complaint that was filed against BioXcel on July 7, 2023 with a Class Period from December 15, 2021 to June 28, 2023. Our investigation concerns whether the board of... ❯❯❯